Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 868 of 1,261

  1. US 8455499

    Alkyne antagonists of lysophosphatidic acid receptors

    AMIRA PHARMACEUTICALS, INC. · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  2. US 8455665

    3-phenoxymethylpyrrolidine compounds

    Theravance, Inc. · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  3. US 8454972

    Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  4. US 8454977

    Non-toxic biofilm inhibitor

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  5. US 8455437

    Method to predict and prevent oxygen-induced inflammatory tissue injury

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  6. US 8455010

    Product and method for producing an immune system supplement and performance enhancer

    Reoxcyn Discoveries Group, Inc. · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  7. US 8455455

    Compositions and methods for silencing genes involved in hemorrhagic fever

    The United States Army Medical Research and Materiel Command · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  8. US 8455493

    Imidazopyrazine Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  9. US 8455564

    Dental composition and composite resin

    JGC Catalysts and Chemicals Ltd. · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  10. US 8455530

    Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

    Theravance, Inc. · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  11. US 8455507

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  12. US 8455565

    Disulfide monomers comprising ethylenically unsaturated groups suitable for dental compositions

    The Regents of the University of Colorado · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  13. US 8455621

    Influenza A virus vaccines and inhibitors

    The Board of Regents of the University of Texas System · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  14. US 8455653

    Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

    TAKEDA GMBH · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  15. US 8455688

    HDAC inhibitors

    Lixte Biotechnology, Inc. · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  16. US 8455497

    Inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  17. US 8454936

    Metal chelators and methods of their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  18. US 8454958

    Methods for detecting and inhibiting angiogenesis

    The Regents of the University of California · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  19. US 8450321

    6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor

    GILEAD CONNECTICUT, INC. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  20. US 8449872

    Polymer conjugates of nesiritide peptides

    Nektar Therapeutics · Granted May 28, 2013 · Expires May 23, 2033

    granted

  21. US 8449875

    Targeting pseudotyped retroviral vectors

    The Regents of the University of California · Granted May 28, 2013 · Expires May 23, 2033

    granted

  22. US 8449876

    Human lysosomal proteins from plant cell culture

    Protalix Ltd. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  23. US 8449911

    Drug composition having active ingredient adhered at high concentration to spherical core

    Takeda Pharmaceutical Company Limited · Granted May 28, 2013 · Expires May 23, 2033

    granted

  24. US 8449884

    Clotting factor-fc chimeric proteins to treat hemophilia

    Syntonix Pharmaceuticals, Inc. · Granted May 28, 2013 · Expires May 23, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.